OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for March, 2014

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2014-03-31 12:15 Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx and more... 2014-03-30 12:15 Amgen Drug Slashes Bad Cholesterol Within Weeks of Treatment 2014-03-29 12:15 Alimera Sciences resubmits Iluvien NDA to US FDA and more... 2014-03-29 00:15 Massachusetts bans sale of FDA-approved Zogenix painkiller and more... 2014-03-28 12:15 Makings of a Wide Moat in Diabetes Care and more... 2014-03-28 00:15 Biotechnology companies hunting for the keys to immortality and more... 2014-03-27 12:15 Social media: a goldmine and a minefield for biopharma and more... 2014-03-27 00:15 Vivus: Shares Are Oversold, Pressure Is On To Secure A Commercial Partner And Drive Market Penetration and more... 2014-03-26 12:15 Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead and more... 2014-03-26 00:15 Biogen cozies up to MIT with a $5.3M drug discovery pact and more... 2014-03-25 12:15 FDA: More Than 3.4 Million Hours Spent Each Year Filing New and Generic Drug Applications and more... 2014-03-25 00:15 Eli Lilly Says Most Employees Won't See Raises in Base Salary This Year and more... 2014-03-24 12:15 BioTime Joins Advanced Cell Technology In The AMD Race and more... 2014-03-23 12:15 Biotech Rival to Teva Blockbuster Said to Seek IPO and more... 2014-03-23 00:15 Novartis chairman stresses need for R&D investment and more... 2014-03-22 00:15 Biotech Stocks Weak on Fear That Gilead Drug Pricing Woes Will Spread and more... 2014-03-21 12:15 They're no Coca-Cola, but top biopharma brands Pfizer, Biogen and Merck still worth billions and more... 2014-03-21 00:15 J&J blazes a new pharma trail with industry's first designer-in-chief and more... 2014-03-20 12:15 Valeant Targets Corporate â?Ç?ÿFatâ?Ç?Ö in Push for Big Leagues and more... 2014-03-20 00:15 Big Pharma Ramps Up Hep C Strategies and more... 2014-03-19 12:15 3 Biotechs With Major Catalysts Incoming and more... 2014-03-19 00:15 Biogen to be added to S&P100 and more... 2014-03-18 12:15 Eager biotechs eye $133M in IPOs as a frenzied quarter closes and more... 2014-03-18 00:15 Tokyo hospital exec says Novartis employees deeply involved in leukemia-drug trial and more... 2014-03-17 12:15 5 Big Pharma Stocks With the Strongest Ties to Emerging Markets and more... 2014-03-17 00:15 Novartis gave doctors thousands to prescribe pills, feds allege and more... 2014-03-16 00:15 Will Obamacare Harm These Biotech Stocks? 2014-03-15 12:15 Orchid Pharma gets nod for CDR and more... 2014-03-14 12:15 Why Teva May Be Back From the Dead and more... 2014-03-14 00:15 With FDA Concerns Public, What's Next for These Cholesterol Drugs? and more... 2014-03-13 12:15 "Close Call" for American Rx Marketers on Medicare Part D and more... 2014-03-13 00:15 Grateful Actavis board adds $4M to CEO's deal-related bonus tally. Total: $49M and more... 2014-03-12 12:15 German med schools perfectly OK with pharma-rep visits and gifts and more... 2014-03-12 00:15 Bayer to invest $700 mln to produce hemophilia drugs in Germany and more... 2014-03-11 12:15 Kythera buys back Bayer's stake in PhIII chin-fat therapy in $84M deal and more... 2014-03-11 00:15 Pfizer Breast-Cancer Drug To Show If It's For Real and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe